Cell-permeable protein inhibitors of calpain

   
   

Fusion proteins have been discovered that contain a calpastatin peptide and a signal sequence capable of delivering the fusion protein into a cell. These proteinS can be used to inhibit calpain and may, more specifically, be used to inhibit platelet aggregation or degranulation; to inhibit or reverse erythrocyte sickling; to inhibit a human immunodeficiency virus (HIV); or to inhibit unwanted cellular proliferation or migration.

Le proteine di fusione sono state scoperte che contengono un peptide di calpastatin e una sequenza del segnale capaci di trasporto della proteina di fusione in una cellula. Queste proteine possono essere usate per inibire il calpain e possono, piĆ¹ specificamente, essere usate per inibire l'aggregazione o il degranulation della piastrina; per inibire o invertire eritrocito che sickling; per inibire un virus umano di immunodeficiency (HIV); o per inibire proliferazione o espansione cellulare indesiderabile.

 
Web www.patentalert.com

< Methods of screening novel agents for use in cancer therapy and prevention

< Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors

> Virus-free plasma protein compositions treated with porous membrane and process for producing the same

> Gapped oligomers having site specific chiral phosphorothioate internucleoside linkages

~ 00167